QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

HAE

QT78Haemonetics Corporation
NYSE·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
74.17
+1.44+1.98%
OverviewShort InterestFilings
HAEQT78Haemonetics Corporation·NYSE
OverviewShort InterestFilings
74.17+1.98%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E35.47EPS (ttm)
2.02
Insider Own2.37%
Shs Outstand45.45M
Perf Week-7.10%
Market Cap3.39BForward P/E12.88EPS next Y5.76Insider Trans0.00%Shs Float-Perf Month30.47%
Enterprise Value4.37BPEG-EPS next Q1.09Inst Own-Short Float-Perf Quarter25.93%
Income95.70MP/S2.54EPS this Y158.35%Inst Trans-Short Ratio-Perf Half Y-8.56%
Sales1.33BP/B4.33EPS next Y10.36%ROA4.06%Short Interest-Perf YTD-7.46%
Book/sh17.51P/C11.77EPS next 5Y12.19%ROE11.32%52W High87.32 -15.06%Perf Year7.48%
Cash/sh5.39P/FCF13.03EPS past 3/5Y-ROIC8.69%52W Low47.32 56.74%Perf 3Y-
Dividend Est.-EV/EBITDA15.60Sales past 3/5Y4.50% 8.92%Gross Margin57.34%Volatility2.77% 3.04%Perf 5Y-
Dividend TTM-EV/Sales3.28EPS Y/Y TTM48.04%Oper. Margin18.15%ATR (14)3.15Perf 10Y-
Dividend Ex-Date-Quick Ratio1.87Sales Y/Y TTM-2.06%Profit Margin7.29%RSI (14)61.31Recom2.50
Dividend Gr. 3/5Y-Current Ratio2.95EPS Q/Q8.40%SMA204.06%Beta0.34Target Price80.33
Payout0.00%Debt/Eq1.54Sales Q/Q4.53%SMA5017.03%Rel Volume0.97Prev Close72.73
Employees3,657LT Debt/Eq1.53EarningsAug 06SMA20016.24%Avg Volume919.68KPrice74.17
IPO DateMay 10, 1991Option/ShortYes / YesEPS/Sales Surpr.0.78% 2.67%Net Debt/EBITDA3.49Volume887,718Change1.98%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-15-26ReiteratedMizuho Securities$70 → $85
May-22-26UpgradeB of A SecuritiesNeutral → Buy
May-12-26ReiteratedBarrington$94 → $89
May-08-26ReiteratedRobert W. Baird$72 → $67
Apr-13-26ReiteratedMizuho Securities$80 → $70
Feb-06-26ReiteratedRobert W. Baird$99 → $81
Feb-06-26ReiteratedBarrington$93 → $94
Feb-06-26ReiteratedMizuho Securities$90 → $80
Jan-12-26ReiteratedBarrington$90 → $93
Dec-17-25ReiteratedMizuho Securities$75 → $90
Latest News
Jun-17-26
Jun-17-2606:00AM
BTIG Reiterates Buy on Haemonetics, Maintains $84 Price TargetBenzinga
Jun-15-26
Jun-15-2601:26PM
Mizuho Maintains Outperform on Haemonetics, Raises Price Target to $85Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2026
3/28/2026
FY 2025
3/29/2025
FY 2024
3/31/2024
FY 2023
3/31/2023
FY 2022
3/31/2022
FY 2021
3/31/2021
FY 2020
3/31/2020
FY 2019
3/31/2019
Total Revenue1,3331,3341,361
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A570590582
Gross Profit764744779
Selling, General and Administrative Excl. Other332442422
Research and Development596069
Other Operating Expense132066
Operating Income242241222
Interest Expense242910
Unusual Expense
———
Non-Operating Income (Expense)7385-25
Net Income Before Taxes128128212
Income Taxes313144
Consolidated Net Income9897168
Net Income From Continuing Operations9897168
Net Income9897168
EPS (Recurring)2.042.053.31
EPS (Basic, Before Extraordinaries)2.042.053.31
EPS (Diluted)2.022.053.31
EBITDA280312356
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio36.7226.36—
Price To Sales Ratio2.561.90—
Gross Margin57.3155.7757.24
Operating Margin18.1518.0716.31
Net Margin7.357.2712.34
Shares Outstanding464750
Market Capitalization3,4122,540—
Operating Lease Expense
———
Insider Trading Volume
$78.34$69.31$60.28$51.25$42.22● Close Price0.00K24.70K49.39K74.09K98.78KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
KROLL MARK WDirectorNov 10 '25Buy70.561,40098,78424,757Nov 12 12:00 AM
Strong Stewart WPresident, Global HospitalJul 26 '24Sale91.154,312393,03918,196Jul 29 12:00 AM
Lingamneni AnilaEVP, Chief Technology OfficerJul 12 '24Sale90.00797,11021,331Jul 15 12:00 AM
Lingamneni AnilaEVP, Chief Technology OfficerJul 11 '24Sale90.002,136192,24021,410Jul 15 12:00 AM
Simon, ChristopherPresident & CEOJun 06 '24Option Exercise41.64209,0328,704,092433,877Jun 07 12:00 AM
Strong Stewart WPresident, Global HospitalMay 29 '24Sale87.538,857775,25318,196May 29 12:00 AM
Basil Michelle LEVP and General CounselMay 29 '24Sale88.0812,9901,144,20931,257May 29 12:00 AM
Strong Stewart WPresident, Global HospitalMay 20 '24Sale95.1168665,24518,196May 21 12:00 AM
Basil Michelle LEVP and General CounselMay 20 '24Sale95.081,604152,50831,257May 21 12:00 AM
Llorens JosepEVP, Global ManufacturingMay 20 '24Sale95.0898793,84421,310May 21 12:00 AM
Strong Stewart WPresident, Global HospitalMay 20 '24Option Exercise56.574,482253,54620,437May 21 12:00 AM
Llorens JosepEVP, Global ManufacturingMay 17 '24Sale94.8282277,94216,350May 21 12:00 AM
Basil Michelle LEVP and General CounselMay 17 '24Sale95.001,073101,93529,352May 21 12:00 AM
Strong Stewart WPresident, Global HospitalMay 16 '24Option Exercise57.604,820277,63218,018May 17 12:00 AM
Strong Stewart WPresident, Global HospitalMay 16 '24Sale96.0473370,39715,608May 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR